Document is current
Any future updates will be listed below
-
Authors
Lindland, Elisabeth S. https://orcid.org/0000-0001-8900-4419
Solheim, Anne Marit
Andreassen, Silje
Bugge, Robin
Eikeland, Randi
Reiso, Harald
Lorentzen, Åslaug R.
Harbo, Hanne F.
Beyer, Mona K.
Bjørnerud, Atle
-
Funding
Funding for this research was provided by:
Helse Sør-Øst RHF (2020103, 2013089)
Norwegian multi regional health authorities (2015113, 2015113, 2015113)
University of Oslo
- License Information
-
More Information
Article History
Received: 4 May 2023
Accepted: 22 June 2023
First Online: 15 September 2023
Declarations
:
: The study was approved by the Norwegian South-Eastern Regional Ethics Committee (2015/1588(11437)). The participants gave written informed consent.
: Not applicable.
: MKB received minor grants or speaker´s fees from Biogen Idec, Merck and Novartis. HFH received minor grants or speaker´s fees from Biogen, Sanofi Genzyme, Teva, and Merck. ÅRL received minor grant from Sanofi. The other authors do not report any disclosures.
